Detalhe da pesquisa
1.
Nuclear Localization Signal Enhances the Targeting and Therapeutic Efficacy of a Porphyrin-Based Molecular Cargo: A Systemic In Vitro and Ex Vivo Evaluation.
Mol Pharm
; 21(5): 2351-2364, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38477252
2.
Peptide-drug conjugate designated for targeted delivery to HER2-expressing cancer cells.
J Pept Sci
; : e3602, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38600778
3.
Synthesis and 177Lu Labeling of the First Retro Analog of the HER2-Targeting A9 Peptide: A Superior Variant.
Bioconjug Chem
; 34(9): 1576-1584, 2023 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379455
4.
Targeting HER2-receptors with 177Lu-labeled triazole stapled cyclic peptidomimetic.
Bioorg Chem
; 135: 106503, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37037128
5.
Design, synthesis and evaluation of 177Lu-labeled inverso and retro-inverso A9 peptide variants targeting HER2-overexpression.
Bioorg Chem
; 140: 106761, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586132
6.
Preparation of radiolabeled erlotinib analogues and analysis of the effect of linkers.
Bioorg Med Chem Lett
; 76: 128995, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152732
7.
Assessment of 177 Lu-labeled carboxyl-terminated polyamidoamine (PAMAM) dendrimer-RGD peptide conjugate.
J Pept Sci
; 28(2): e3366, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463002
8.
Recent Breakthrough in 68Ga-Radiopharmaceuticals Cold Kits for Convenient PET Radiopharmacy.
Bioconjug Chem
; 32(3): 430-447, 2021 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33630583
9.
68 Ga-labeling of internalizing RGD (iRGD) peptide functionalized with DOTAGA and NODAGA chelators.
J Pept Sci
; 26(3): e3241, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31984553
10.
Design, synthesis, and comparative evaluation of 99m Tc(CO)3 -labeled N-terminal and C-terminal modified asparagine-glycine-arginine peptide constructs.
J Pept Sci
; 25(7): e3192, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31309677
11.
Synthesis, radiolabeling, and evaluation of gastrin releasing peptide receptor antagonist 68 Ga-HBED-CC-RM26.
J Labelled Comp Radiopharm
; 62(12): 843-849, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31378967
12.
Preparation and comparative evaluation of 99m Tc-HYNIC-cNGR and 99m Tc-HYNIC-PEG2 -cNGR as tumor-targeting molecular imaging probes.
J Labelled Comp Radiopharm
; 61(2): 68-76, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29139598
13.
99m Tc-labeled NGR-chlorambucil conjugate, 99m Tc-HYNIC-CLB-c(NGR) for targeted chemotherapy and molecular imaging.
J Labelled Comp Radiopharm
; 60(9): 431-438, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28545160
14.
Cerenkov luminescence imaging of αv ß6 integrin expressing tumors using (90) Y-labeled peptides.
J Labelled Comp Radiopharm
; 57(9): 558-65, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25042833
15.
[99mTc]Tc-HYNIC-RM2: A potential SPECT probe targeting GRPR expression in prostate cancers.
Nucl Med Biol
; 118-119: 108331, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36933456
16.
Synthesis and comparative evaluation of 177Lu-labeled PEG and non-PEG variant peptides as HER2-targeting probes.
Sci Rep
; 12(1): 15720, 2022 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36127494
17.
Evaluation of the effect of a cell penetrating peptide (TAT) towards tailoring the targeting efficacy and tumor uptake of porphyrin.
RSC Med Chem
; 13(11): 1378-1390, 2022 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36439980
18.
Single vial cold kits optimized for preparation of gastrin releasing peptide receptor (GRPR)-radioantagonist 68Ga-RM2 using three different 68Ge/68Ga generators.
J Pharm Biomed Anal
; 163: 39-44, 2019 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30278325
19.
Preparation and clinical translation of 99mTc-PSMA-11 for SPECT imaging of prostate cancer.
Medchemcomm
; 10(12): 2111-2117, 2019 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32190233
20.
Synthesis of 99mTc-nitrido heterocomplex of piperidine and in vitro and in vivo evaluation of its affinity for sigma receptors.
Cancer Biother Radiopharm
; 23(1): 34-42, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18298327